News
26th May 2011
'In the past few years there has been considerable debate over the quality requirements applicable to the Artemisinin ...'
______________________________________________________________________________
20th May 2011
Complement Genomics gains first-ever accreditation for key anti-malarial drug test
'The innovative North East based biotechnology company Complement Genomics Ltd, has developed a new technique to measure the purity/quality of the key anti-malarial drug artemisinin...'